Improving the production of valuable fungal products and enzymes
Official title: A Universal Fungal Transposase System for Increasing Natural Product and Protein Titers
Funded at Varigen Biosciences Corporation · NIH-10760459 · Data updated 2026-11-12
This study is looking at ways to help fungi produce more natural products and enzymes that are useful for things like medicine and farming, which could eventually lead to better and faster access to important treatments and products for everyone.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Varigen Biosciences Corporation NIH-funded |
| Lab location | 1 site (Middleton, UNITED STATES) |
| Project start | September 5, 2023 |
| Project end | August 31, 2025 |
| Funding year | 2023 |
| Award (this year) | $295,306 |
| NIH project number | 1R43AT012434-01A1 |
| Project ID | NIH-10760459 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research include individuals who rely on agricultural products and pharmaceuticals derived from fungal sources.
✕Less likely to help
Patients who do not utilize agricultural or fungal-derived pharmaceutical products may not receive direct benefits from this research.
What this research studies
This research focuses on enhancing the production of natural products and enzymes derived from fungi, which are important for various industries, including agriculture and pharmaceuticals. By utilizing advanced synthetic biology techniques and transposase technologies, the project aims to create more efficient fungal strains that can produce higher quantities of these valuable compounds. This could lead to faster development timelines and improved access to essential products that benefit multiple sectors. Patients may indirectly benefit from this research through advancements in pharmaceuticals and agricultural products that arise from enhanced fungal production.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective and accessible agricultural and pharmaceutical products for patients.
How similar studies have gone: Other research has shown success in enhancing microbial production through synthetic biology approaches, indicating potential for this novel method.
Where this research is happening
-
Varigen Biosciences Corporation
Middleton, United States Active
Researchers
- Principal investigator: Knox, Ben — Varigen Biosciences Corporation
- Study coordinator: Knox, Ben
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.